FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Antonio Pezzutto

Research Profile

Anatomy

Physiology

Lymphocyte Activation

Chemicals & Drugs

Disorders

Procedures

Living Beings

Mouse

Co-author Network

Publications

TOP 3
Christian W Scholz; Andrea Stroux; Andreas Viardot; Antonello Pinto; Christiane Pott; Manuela Arcamone; Bernd Frericks; Ferdinando Frigeri; Georg Hess; Ulrich Keller; Secondo Lastoria; Kristina Lerch; Ola Lindén; Werner Linkesch; Antonio Pezzutto
(90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial.
Oliver Schmetzer; Gerhard Moldenhauer; Annett Nicolaou; Rainer Riesenberg; Peter Schlag; Antonio Pezzutto
Detection of circulating tumor-associated antigen depends on the domains recognized by the monoclonal antibodies used: N-terminal trimmed EpCAM-levels are much higher than untrimmed forms.
Anne Flörcken; Werner Hopfenmüller; Antonio Pezzutto; Anju Singh; Anna Takvorian; Antje van Lessen; Bernd Dörken; Jörg Westermann
Sorafenib, but not sunitinib, induces regulatory T cells in the peripheral blood of patients with metastatic renal cell carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Antonio Pezzutto (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Christian W Scholz; Andrea Stroux; Andreas Viardot; Antonello Pinto; Christiane Pott; Manuela Arcamone; Bernd Frericks; Ferdinando Frigeri; Georg Hess; Ulrich Keller; Secondo Lastoria; Kristina Lerch; Ola Lindén; Werner Linkesch; Antonio Pezzutto
(90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(3):308-13.
2012: Oliver Schmetzer; Gerhard Moldenhauer; Annett Nicolaou; Rainer Riesenberg; Peter Schlag; Antonio Pezzutto
Detection of circulating tumor-associated antigen depends on the domains recognized by the monoclonal antibodies used: N-terminal trimmed EpCAM-levels are much higher than untrimmed forms.
Immunology letters 2012;143(2):184-92.
2012: Anne Flörcken; Werner Hopfenmüller; Antonio Pezzutto; Anju Singh; Anna Takvorian; Antje van Lessen; Bernd Dörken; Jörg Westermann
Sorafenib, but not sunitinib, induces regulatory T cells in the peripheral blood of patients with metastatic renal cell carcinoma.
Anti-cancer drugs 2012;23(3):298-302.
2012: Tam Nguyen-Hoai; Antonio Pezzutto; Minh Pham-Duc; Mona Sayed Ahmed; Gerd Baldenhofer; Bernd Dörken; Margarete Gries; Martin Lipp; Jörg Westermann
CCL19 (ELC) improves TH1-polarized immune responses and protective immunity in a murine Her2/neu DNA vaccination model.
The journal of gene medicine 2012;14(2):128-37.
2012: Heike Pohla; Tim Schwachula; Birgit Stadlbauer; Stefan Stevanovic; Christian G Stief; Steffen Walter; Gerald Willimsky; Thomas Blankenstein; Alexander Buchner; Ronald Frank; Bernhard Frankenberger; Alfons Hofstetter; Joachim Kopp; Ralph Oberneder; Sven Olek; Antonio Pezzutto; Dolores J Schendel
High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination.
Molecular medicine (Cambridge, Mass.) 2012;18():1499-508.
2011: Helmar Waiczies; Ulrike Hagen; Bernd Ittermann; Nicole Janitzek; Stefano Lepore; Thoralf Niendorf; Friedemann Paul; Antonio Pezzutto; Bettina Purfürst; Frank Seifert; Sonia Waiczies
Perfluorocarbon particle size influences magnetic resonance signal and immunological properties of dendritic cells.
PloS one 2011;6(7):e21981.
2010: Alexander Buchner; Heike Pohla; Gerald Willimsky; Bernhard Frankenberger; Ronald Frank; Andrea Baur-Melnyk; Michael Siebels; Christian G Stief; Alfons Hofstetter; Joachim Kopp; Antonio Pezzutto; Thomas Blankenstein; Ralph Oberneder; Dolores Schendel
Phase 1 trial of allogeneic gene-modified tumor cell vaccine RCC-26/CD80/IL-2 in patients with metastatic renal cell carcinoma.
Human gene therapy 2010;21(3):285-97.
2009: Carmela Foti; Cristina Florean; Antonio Pezzutto; Paola Roncaglia; Andrea Tomasella; Stefano Gustincich; Claudio Brancolini
Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system.
Molecular cancer therapeutics 2009;8(11):3140-50.
2009: Jörg Westermann; Ann-Christine Hecker; Anne Flörcken; Bernd Dörken; Antonio Pezzutto
Granulocyte macrophage-colony stimulating factor plus interleukin-2 plus alpha-interferon plus 5-fluorouracil in the treatment of metastatic renal cell cancer: induction of CD80/86+ T cells indicates adverse outcome.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(6):667-75.
2008: Katja C Weisel; Eckhart Weidmann; Ioannis Anagnostopoulos; Lothar Kanz; Antonio Pezzutto; Marion Subklewe
Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphoma.
International journal of hematology 2008;88(4):434-40.
2008: Isrid Sturm; Joachim Oertel; Stephan Oertel; Jörg Westermann; Antonio Pezzutto
Successful long-term monotherapy with rituximab in a patient with chronic lymphocytic leukemia of the B-cell-lineage: a case report.
Journal of medical case reports 2008;2():275.
2007: J Westermann; T Nguyen-Hoai; G Baldenhofer; Uta E Höpken; Martin Lipp; Bernd Dörken; Antonio Pezzutto
CCL19 (ELC) as an adjuvant for DNA vaccination: induction of a TH1-type T-cell response and enhancement of antitumor immunity.
Cancer gene therapy 2007;14(6):523-32.
2007: Jörg Westermann; Joachim Kopp; Antje van Lessen; Ann-Christine Hecker; Gökben Baskaynak; Philipp le Coutre; Konstanze Döhner; Hartmut Döhner; Bernd Dörken; Antonio Pezzutto
Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia.
British journal of haematology 2007;137(4):297-306.
2007: Kathrin Sebelin-Wulf; Tuan D Nguyen; Stephan Oertel; Matthias Papp-Vary; Ralf Ulrich Trappe; Antje Schulzki; Antonio Pezzutto; Hanno Riess; Marion Subklewe
Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD.
Transplant immunology 2007;17(3):203-10.
2007: Marion Subklewe; Kathrin Sebelin-Wulf; Carola Beier; Andreas Lietz; Stephan Mathas; Bernd Dörken; Antonio Pezzutto
Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib.
Human immunology 2007;68(3):147-55.
2007: Bert Hildebrandt; C Müller; Antonio Pezzutto; Pt Daniel; Bernd Dörken; Christa Scholz
Assessment of free light chains in the cerebrospinal fluid of patients with lymphomatous meningitis - a pilot study.
BMC cancer 2007;7():185.
2006: Marion Subklewe; René Marquis; Sylvain Choquet; Véronique Leblond; Jeanne-Luce Garnier; Roland Hetzer; Lode J Swinnen; Stephan Oertel; Matthias Papp-Vary; Eva Gonzalez-Barca; Bouke G Hepkema; Constanze Schoenemann; May Jürgen; Antonio Pezzutto; Hanno Riess
Association of human leukocyte antigen haplotypes with posttransplant lymphoproliferative disease after solid organ transplantation.
Transplantation 2006;82(8):1093-100.
2006: Kathrin Sebelin; Antje Schulzki; Peter-M Kloetzel; Bernd Dörken; Antonio Pezzutto; Marion Subklewe
Impairment of circulating myeloid dendritic cells in immunosuppressed renal/pancreas transplant recipients.
Transplantation 2006;82(6):779-87.
2006: Jörg Westermann; Antje Lessen; Claudia Schlimper; Gökben Baskaynak; Philipp le Coutre; Bernd Dörken; Antonio Pezzutto
Simultaneous cytokine analysis by cytometric bead array for the detection of leukaemia-reactive T cells in patients with chronic myeloid leukaemia.
British journal of haematology 2006;132(1):32-5.
2005: Jörg Westermann; Georg Maschmeyer; Antje van Lessen; Bernd Dörken; Antonio Pezzutto
CD52 is not a promising immunotherapy target for most patients with multiple myeloma.
International journal of hematology 2005;82(3):248-50.
2005: Maren Bienert; Ingrid Reisinger; Stefanie Srock; Beatrice I Humplik; Christel Reim; Thomas Kroessin; Norbert Avril; Antonio Pezzutto; Dieter L Munz
Radioimmunotherapy using 131I-rituximab in patients with advanced stage B-cell non-Hodgkin's lymphoma: initial experience.
European journal of nuclear medicine and molecular imaging 2005;32(10):1225-33.
2005: Bernhard Frankenberger; Sybille Regn; Christiane Geiger; Elfriede Noessner; Christine S Falk; Heike Pohla; Miran Javorovic; Tobias Silberzahn; Susanne Wilde; Alexander Buchner; Michael Siebels; Ralph Oberneder; Gerald Willimsky; Antonio Pezzutto; Thomas Blankenstein; Dolores Schendel
Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells.
World journal of urology 2005;23(3):166-74.
2005: Bernhard Frankenberger; Heike Pohla; Elfriede Noessner; Gerald Willimsky; Britta Papier; Antonio Pezzutto; Joachim Kopp; Ralph Oberneder; Thomas Blankenstein; Dolores Schendel
Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(5):1733-42.
2005: Oliver Schmetzer; Gerhard Moldenhauer; Rainer Riesenberg; Juliana Rico Pires; Peter Schlag; Antonio Pezzutto
Quality of recombinant protein determines the amount of autoreactivity detected against the tumor-associated epithelial cell adhesion molecule antigen: low frequency of antibodies against the natural protein.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(2):942-52.
2004: J Westermann; T Nguyen-Hoai; A Mollweide; G Richter; Oliver Schmetzer; H-J Kim; Thomas Blankenstein; Bernd Dörken; Antonio Pezzutto
Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization.
Gene therapy 2004;11(13):1048-56.
2004: Jörg Westermann; Claudia Schlimper; Günther Richter; Johannes Mohm; Bernd Dörken; Antonio Pezzutto
T cell recognition of bcr/abl in healthy donors and in patients with chronic myeloid leukaemia.
British journal of haematology 2004;125(2):213-6.
2003: Richard F Schlenk; Axel Benner; Frank Hartmann; F del Valle; C Weber; Hans Pralle; J Th Fischer; U Gunzer; Antonio Pezzutto; W Weber; Wolfgang Grimminger; J Preiss; M Hensel; Stefan Fröhling; Konstanze Döhner; Rainer Haas; Hartmut Döhner
Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial.
Leukemia 2003;17(8):1521-8.
2003: Jörg Westermann; Ida J Körner; Joachim Kopp; Steffen M Kurz; Martin Zenke; Bernd Dörken; Antonio Pezzutto
Cryopreservation of mature monocyte-derived human dendritic cells for vaccination: influence on phenotype and functional properties.
Cancer immunology, immunotherapy : CII 2003;52(3):194-8.
2001: G Richter; Martha Hayden-Ledbetter; M Irgang; Jeffrey A Ledbetter; J Westermann; Ida J Körner; K Daemen; Edward A Clark; Alexandra Aicher; Antonio Pezzutto
Tumor necrosis factor-alpha regulates the expression of inducible costimulator receptor ligand on CD34(+) progenitor cells during differentiation into antigen presenting cells.
The Journal of biological chemistry 2001;276(49):45686-93.
2001: Jörg Westermann; Gernot Reich; J Kopp; U Haus; Bernd Dörken; Antonio Pezzutto
Granulocyte/macrophage-colony-stimulating-factor plus interleukin-2 plus interferon alpha in the treatment of metastatic renal cell carcinoma: a pilot study.
Cancer immunology, immunotherapy : CII 2001;49(11):613-20.
2000: Heike Pohla; Bernhard Frankenberger; B Stadlbauer; Ralph Oberneder; Alfons Hofstetter; Gerald Willimsky; Antonio Pezzutto; Bernd Dörken; Thomas Blankenstein; Dolores Schendel
Allogeneic vaccination for renal cell carcinoma: development and monitoring.
Bone marrow transplantation 2000;25 Suppl 2():S83-7.
2000: Jörg Westermann; Joachim Kopp; Ida J Körner; G Richter; Z Qin; Thomas Blankenstein; Bernd Dörken; Antonio Pezzutto
Bcr/abl+ autologous dendritic cells for vaccination in chronic myeloid leukemia.
Bone marrow transplantation 2000;25 Suppl 2():S46-9.
2000: Alexandra Aicher; Martha Hayden-Ledbetter; W A Brady; Antonio Pezzutto; G Richter; Dario M Magaletti; S Buckwalter; Jeffrey A Ledbetter; Edward A Clark
Characterization of human inducible costimulator ligand expression and function.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(9):4689-96.
1999: Alexandra Aicher; Geraldine L Shu; Dario M Magaletti; Thera M Mulvania; Antonio Pezzutto; Andrew Craxton; Edward A Clark
Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(11):5786-95.
1999: Peter Daniel; Christian Scholz; Frank Essmann; J Westermann; Antonio Pezzutto; Bernd Dörken
CD95/Fas-triggered apoptosis of activated T lymphocytes is prevented by dendritic cells through a CD58-dependent mechanism.
Experimental hematology 1999;27(9):1402-8.
1999: S Cayeux; G Richter; Christian Becker; Antonio Pezzutto; Bernd Dörken; Thomas Blankenstein
Direct and indirect T cell priming by dendritic cell vaccines.
European journal of immunology 1999;29(1):225-34.
1998: Peter Daniel; A Kroidl; J Kopp; Isrid Sturm; G Moldenhauer; Bernd Dörken; Antonio Pezzutto
Immunotherapy of B-cell lymphoma with CD3x19 bispecific antibodies: costimulation via CD28 prevents "veto" apoptosis of antibody-targeted cytotoxic T cells.
Blood 1998;92(12):4750-7.
1998: Nadia Rinaldi; Thomas F E Barth; D Weis; M Schwarz-Eywill; Antonio Pezzutto; Martin Lukoschek; Dario R C Brocai; B Brado
Loss of laminin and of the laminin receptor integrin subunit alpha 6 in situ correlates with cytokine induced down regulation of alpha 6 on fibroblast-like synoviocytes from rheumatoid arthritis.
Annals of the rheumatic diseases 1998;57(9):559-65.
1998: J Westermann; Alexandra Aicher; Z Qin; Z Cayeux; K Daemen; Thomas Blankenstein; Bernd Dörken; Antonio Pezzutto
Retroviral interleukin-7 gene transfer into human dendritic cells enhances T cell activation.
Gene therapy 1998;5(2):264-71.
1998: Peter Daniel; A Kroidl; S Cayeux; C Scholz; Isrid Sturm; Thomas Blankenstein; Antonio Pezzutto; Bernd Dörken
Retroviral B7.1 gene transfer in cancer cells protects cytotoxic T cells from deletion by "veto" apoptosis.
Advances in experimental medicine and biology 1998;451():265-76.
1998: Peter Daniel; C Scholz; J Westermann; Bernd Dörken; Antonio Pezzutto
Dendritic cells prevent CD95 mediated T lymphocyte death through costimulatory signals.
Advances in experimental medicine and biology 1998;451():173-7.
1998: J Westermann; Alexandra Aicher; Antonio Pezzutto
Dendritic cells for somatic gene therapy.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1998;144():70-7.
1997: Nadia Rinaldi; D Weis; B Brado; M Schwarz-Eywill; Martin Lukoschek; Antonio Pezzutto; Ulrich Keilholz; Thomas F E Barth
Differential expression and functional behaviour of the alpha v and beta 3 integrin subunits in cytokine stimulated fibroblast-like cells derived from synovial tissue of rheumatoid arthritis and osteoarthritis in vitro.
Annals of the rheumatic diseases 1997;56(12):729-36.
1997: S Cayeux; G Richter; Christian Becker; C Beck; Alexandra Aicher; Antonio Pezzutto; Bernd Dörken; Thomas Blankenstein
Lack of correlation between rejection of tumor cells co-expressing interleukin-2 and B7.1 and vaccine efficiency.
European journal of immunology 1997;27(7):1657-62.
1997: Alexandra Aicher; J Westermann; S Cayeux; Gerald Willimsky; K Daemen; Thomas Blankenstein; Wolfgang Uckert; Bernd Dörken; Antonio Pezzutto
Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells.
Experimental hematology 1997;25(1):39-44.
1994: C Fiehn; Antonio Pezzutto; W Hunstein
Superficial migratory thrombophlebitis in a patient with reversible protein C deficiency and anticardiolipin antibodies.
Annals of the rheumatic diseases 1994;53(12):843-4.
1993: B Heilig; Antonio Pezzutto; Martin Lukoschek; W Hunstein
[Expression of TNF receptors in rheumatoid arthritis and ankylosing spondylitis].
Zeitschrift für Rheumatologie 1993;52(6):383-9.
1993: B Heilig; C Fiehn; M Brockhaus; H Gallati; Antonio Pezzutto; W Hunstein
Evaluation of soluble tumor necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematodes, progressive systemic sclerosis, and mixed connective tissue disease.
Journal of clinical immunology 1993;13(5):321-8.
1993: M Schwarz-Eywill; A Breitbart; Elena Csernok; Antonio Pezzutto; Wolfgang L Gross
Treatment modalities and ANCA in Takayasu's arteritis.
Advances in experimental medicine and biology 1993;336():497-501.
1992: B Brado; Ulrich Keilholz; Wolfgang Tilgen; Antonio Pezzutto; M Gissler; W Hunstein
[Chilblain lupus erythematosus. A case report].
Der Internist 1992;33(10):701-3.
1992: M Schwarz-Eywill; B Heilig; H Bauer; A Breitbart; Antonio Pezzutto
Evaluation of serum ferritin as a marker for adult Still's disease activity.
Annals of the rheumatic diseases 1992;51(5):683-5.
1992: C Fiehn; M Wermann; Antonio Pezzutto; M Hüfner; B Heilig
[Plasma GM-CSF concentrations in rheumatoid arthritis, systemic lupus erythematosus and spondyloarthropathy].
Zeitschrift für Rheumatologie 1992;51(3):121-6.
1992: Frank G Holz; Hermann Krastel; A Breitbart; M Schwarz-Eywill; Antonio Pezzutto; Hans E Völcker
Low-dose methotrexate treatment in noninfectious uveitis resistant to corticosteroids.
German journal of ophthalmology 1992;1(3-4):142-4.
1992: B Heilig; M Wermann; H Gallati; M Brockhaus; B Berke; O Egen; Antonio Pezzutto; W Hunstein
Elevated TNF receptor plasma concentrations in patients with rheumatoid arthritis.
The Clinical investigator 1992;70(1):22-7.
1991: M Schwarz-Eywill; A Breitbart; Antonio Pezzutto; Hermann Krastel
[Uveitis: occurrence in rheumatic diseases and immunosuppressive therapy].
Immunität und Infektion 1991;19(3):90-1.
1990: T B Barrett; Geraldine L Shu; Kevin E Draves; Antonio Pezzutto; Edward A Clark
Signaling through CD19, Fc receptors or transforming growth factor-beta: each inhibits the activation of resting human B cells differently.
European journal of immunology 1990;20(5):1053-9.
1989: S Cayeux; Stefan C Meuer; Antonio Pezzutto; M Körbling; Rainer Haas; R Schulz; Bernd Dörken
T-cell ontogeny after autologous bone marrow transplantation: failure to synthesize interleukin-2 (IL-2) and lack of CD2- and CD3-mediated proliferation by both CD4- and CD8+ cells even in the presence of exogeneous IL-2.
Blood 1989;74(6):2270-7.
1989: S Cayeux; Stefan C Meuer; Antonio Pezzutto; M Körbling; Rainer Haas; R Schulz; Bernd Dörken
Allogeneic mixed lymphocyte reactions during a second round of ontogeny: normal accessory cells did not restore defective interleukin-2 (IL-2) synthesis in T cells but induced responsiveness to exogeneous IL-2.
Blood 1989;74(6):2278-84.
1989: S Kiesel; Antonio Pezzutto; M Körbling; Rainer Haas; R Schulz; W Hunstein; Bernd Dörken
Autologous peripheral blood stem cell transplantation: analysis of autografted cells and lymphocyte recovery.
Transplantation proceedings 1989;21(1 Pt 3):3084-8.
1988: S Kiesel; Antonio Pezzutto; Gerhard Moldenhauer; Rainer Haas; M Körbling; W Hunstein; Bernd Dörken
B-cell proliferative and differentiative responses after autologous peripheral blood stem cell or bone marrow transplantation.
Blood 1988;72(2):672-8.
1988: S Kiesel; Antonio Pezzutto; Rainer Haas; Gerhard Moldenhauer; Bernd Dörken
Functional evaluation of CD19- and CD22-negative variants of B-lymphoid cell lines.
Immunology 1988;64(3):445-50.
1988: Antonio Pezzutto; Peter S Rabinovitch; B Dörken; G Moldenhauer; Edward A Clark
Role of the CD22 human B cell antigen in B cell triggering by anti-immunoglobulin.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(6):1791-5.
1988: S Kiesel; Gerhard Moldenhauer; Antonio Pezzutto; Rainer Haas; Bernd Dörken
Complement-mediated cytolysis: quantification of B cell surface antigen molecules and role of cell cycle.
Immunology letters 1988;17(3):241-7.
1987: S Kiesel; Rainer Haas; Gerhard Moldenhauer; Gunnar Kvalheim; Antonio Pezzutto; Bernd Dörken
Removal of cells from a malignant B-cell line from bone marrow with immunomagnetic beads and with complement and immunoglobulin switch variant mediated cytolysis.
Leukemia research 1987;11(12):1119-25.
1986: Bernd Dörken; Gerhard Moldenhauer; Antonio Pezzutto; R Schwartz; A Feller; S Kiesel; Lee M Nadler
HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1986;136(12):4470-9.